Nature
-
Bone marrow plasma cells producing antibodies to the SARS-CoV-2 spike protein likely provide robust and long-lived immunity after mild COVID-19.
pearl
Bone marrow plasma cells producing antibodies to the SARS-CoV-2 spike protein likely provide robust and long-lived immunity after mild COVID-19.
pearl